Skip to Content

Notice

Peripheral and Central Nervous System Drugs Advisory Committee; Cancellation

A Notice by the Food and Drug Administration on 04/24/2003

  • PDF
  • Document Details
  • Table of Contents
  • Public Comments
  • Regulations.gov Data
  • Sharing
  • Print
  • Document Statistics
  • Other Formats
Published Document: 03-10150 (68 FR 20158)

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Document Headings

Document headings vary by document type but may contain the following:

  1. the agency or agencies that issued and signed a document
  2. the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to
  3. the agency docket number / agency internal file number
  4. the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions

See the Document Drafting Handbook for more details.

Department of Health and Human Services
Food and Drug Administration

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is cancelling the meeting of the Peripheral and Central Nervous System Drugs Advisory Committee scheduled for May 16, 2003. This meeting was announced in the Federal Register of April 14, 2003 (68 FR 17958).

FOR FURTHER INFORMATION CONTACT:

Karen M. Templeton-Somers, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area) code 12543, or e-mail: .

( printed page 20159)

Dated: April 18, 2003.

Lester M. Crawford,

Deputy Commissioner.

[FR Doc. 03-10150 Filed 4-23-03; 8:45 am]

BILLING CODE 4160-01-S

Published Document: 03-10150 (68 FR 20158)